WOBURN, Mass.--(BUSINESS WIRE)--Courtagen Life Sciences, Inc., a molecular information company that brings comprehensive neurological genome analysis to routine clinical care, announced a collaboration with Astellas Pharma Inc. Courtagen will utilize its molecular information platform to aid in the development of a predictive model to support early stage therapeutic development for mitochondrial disease.
“Astellas and Courtagen share a commitment to innovative clinical solutions that address the needs of patients suffering from mitochondrial based disorders,” states Brian McKernan, Chief Executive Officer of Courtagen. “Courtagen was founded on the idea of helping patients suffering from mitochondrial disorders, and now we are able to utilize our unique capability to correlate clinical data with specific genomic alterations and aid in the development of targeted therapeutics.”
To learn more, follow Courtagen on social media with Facebook, Twitter, and Instagram.
About Astellas
Astellas Pharma Inc., based in Tokyo, Japan,
is a company dedicated to improving the health of people around the
world through the provision of innovative and reliable pharmaceutical
products. We focus on Urology, Oncology, Immunology, Nephrology and
Neuroscience as prioritized therapeutic areas while advancing new
therapeutic areas and discovery research leveraging new
technologies/modalities. We are also creating new value by combining
internal capabilities and external expertise in the medical/healthcare
business. Astellas is on the forefront of healthcare change to turn
innovative science into value for patients. For more information, please
visit our website at http://www.astellas.com/en.
About Courtagen Life Sciences, Inc.
Courtagen Life Sciences,
Inc., located in Woburn, MA, is a CLIA/CAP certified molecular
information company focused on the diagnosis of a range of neurological
disorders. Courtagen operates a highly sophisticated Next Generation DNA
Sequencing, bioinformatics, and clinical interpretation business.
Courtagen’s work helps physicians elucidate the linkages between the
genotypes and phenotypes of various neurological diseases. For more
information, please visit http://www.courtagen.com/.
